Cargando…

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

BACKGROUND: The quality of warfarin anticoagulation among Sub-Saharan African patients is suboptimal. This is due to several factors, including a lack of standardized dosing algorithms, difficulty in providing timely international normalized ratio (INR) results, a lack of patient feedback on their e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorgensen, Andrea L, Orrell, Catherine, Waitt, Catriona, Toh, Cheng-Hock, Sekaggya-Wiltshire, Christine, Hughes, Dyfrig A, Allen, Elizabeth, Okello, Emmy, Tatz, Gayle, Culeddu, Giovanna, Asiimwe, Innocent G, Semakula, Jerome Roy, Mouton, Johannes P, Cohen, Karen, Blockman, Marc, Lamorde, Mohammed, Pirmohamed, Munir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2023
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398551/ https://www.ncbi.nlm.nih.gov/pubmed/37467034 http://dx.doi.org/10.2196/46710

Ejemplares similares

A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa
por: Semakula, Jerome Roy, et al.
Publicado: (2020)

A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

Improving anticoagulation in sub‐Saharan Africa: What are the challenges and how can we overcome them?
por: Mouton, Johannes P., et al.
Publicado: (2021)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Warfarin dosing algorithms: A systematic review
por: Asiimwe, Innocent G., et al.
Publicado: (2020)

Comparative effectiveness of dabigatran, rivaroxaban, apixaban and warfarin in the management of patients with non-valvular atrial fibrillation
por: Pink, Joshua, et al.
Publicado: (2013)

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses
por: Pink, Joshua, et al.
Publicado: (2011)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
por: Asiimwe, Innocent G, et al.
Publicado: (2022)

Warfarin: better the devil you know
por: Blockman, Marc
Publicado: (2017)

Warfarin: The End or the End of One Size Fits All Therapy?
por: Pirmohamed, Munir
Publicado: (2018)

Serious adverse drug reactions in sub‐Saharan Africa in the era of antiretroviral treatment: A systematic review
por: Mouton, Johannes P., et al.
Publicado: (2021)

A multi-factorial analysis of response to warfarin in a UK prospective cohort
por: Bourgeois, Stephane, et al.
Publicado: (2016)

Prevalence and factors associated with psychological distress among patients on warfarin at the Uganda Heart Institute, Mulago Hospital
por: Naisanga, Molly, et al.
Publicado: (2022)

Direct oral anticoagulants versus warfarin: is new always better than the old?
por: Burn, John, et al.
Publicado: (2018)

A Review of A Priori Regression Models for Warfarin Maintenance Dose Prediction
por: Francis, Ben, et al.
Publicado: (2014)

Monocyte unresponsiveness and impaired IL1β, TNFα and IL7 production are associated with a poor outcome in Malawian adults with pulmonary tuberculosis
por: Waitt, Catriona John, et al.
Publicado: (2015)

Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials
por: Johnson, Danielle, et al.
Publicado: (2019)

Cardiovascular drugs and COVID‐19 clinical outcomes: A living systematic review and meta‐analysis
por: Asiimwe, Innocent G., et al.
Publicado: (2021)

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Early Deaths During Tuberculosis Treatment Are Associated With Depressed Innate Responses, Bacterial Infection, and Tuberculosis Progression
por: Waitt, Catriona John, et al.
Publicado: (2011)

Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions
por: Osanlou, Rostam, et al.
Publicado: (2022)

Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs
por: Waitt, Catriona, et al.
Publicado: (2018)

Leveraging investments in Ebola preparedness for COVID-19 in Sub-Saharan Africa
por: Ayebare, Rodgers, et al.
Publicado: (2020)

High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily
por: Seden, Kay, et al.
Publicado: (2018)

Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS
por: Waitt, Catriona, et al.
Publicado: (2017)

Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial
por: Byonanebye, Dathan Mirembe, et al.
Publicado: (2021)

Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis
por: Jorgensen, Andrea L., et al.
Publicado: (2012)

An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)
por: Walimbwa, Stephen I., et al.
Publicado: (2021)

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)
por: Nabisere, Ruth, et al.
Publicado: (2020)

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
por: Kaboggoza, Julian P, et al.
Publicado: (2019)

Pharmacogenetics of warfarin in a paediatric population: Time in therapeutic range, initial and stable dosing, and adverse effects
por: Hawcutt, Daniel B, et al.
Publicado: (2014)

1762. Clinical application of handheld ultrasound devices during the 2022 Sudan Virus disease Ebola outbreak in Uganda
por: Kayiira, Mubaraka, et al.
Publicado: (2023)

Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study
por: Jorgensen, Andrea L., et al.
Publicado: (2019)

“It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

‘I fear my partner will abandon me’: the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies
por: Waitt, Catriona John, et al.
Publicado: (2015)

A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
por: Ochanda, Perez Nicholas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1u3n2d99g0e4j98mt6mo3run08